WALTHAM, MA — Revvity (NYSE: RVTY), announced the launch of the Fontus™ Automated Liquid Handling Workstation, a next-generation liquid handler incorporating the best technologies from Revvity’s existing platforms, designed to deliver easier and faster workflows that enable better results for next generation sequencing (NGS) and diagnostic research applications.
An upgraded automation workstation founded on well-established technologies
The Fontus workstation features streamlined software, tube-to-plate reformatting, 96 or 384 array head with partial tip loading and integrated peripherals, such as on-deck thermocycler, temperature modules and up to two labware grippers. The system provides improved usability compared to existing Revvity platforms, offering users greater deck access and ergonomics, and an improved enclosure.
Available in a pre-configured NGS model, the Fontus workstation is designed to support fast and accurate NGS library prep automation using proven, vendor-qualified automated methods. The easy-to-use software and access to Revvity’s dedicated support team of automated liquid handling and NGS application experts are provided so users can reduce start up time, optimize their workflows and focus on the science. To support environmental sustainability, the separate waste chutes for recyclables and biohazard waste allow users to easily separate the two, and the workstation integrates extra labware storage without additional footprint to remove the need for an external robot or more bench space.
“The growth of NGS demands consistent quality library prep and higher throughput,” said Yves Dubaquie, Revvity’s senior vice president, diagnostics. “The Fontus workstation was designed to meet these expectations with pre-developed methods based on models developed and perfected by our experts over the past 35 years. It’s well suited for a wide range of liquid handling applications and will be especially valuable in this climate where supply of talented lab personnel is limited while more work needs to be accomplished in a timely manner.”
Available globally for pharmaceutical and biotechnology companies, contract research organizations (CROs), diagnostic labs, academia, and governments, Revvity is in the process of obtaining IVDR registration for the Fontus workstation with shipments beginning imminently.